These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3789003)

  • 1. An evaluation of spontaneous adverse drug reaction monitoring systems.
    Sachs RM; Bortnichak EA
    Am J Med; 1986 Nov; 81(5B):49-55. PubMed ID: 3789003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions.
    Wysowski DK; Swartz L
    Arch Intern Med; 2005 Jun; 165(12):1363-9. PubMed ID: 15983284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing reporting rates of adverse events between drugs with adjustment for year of marketing and secular trends in total reporting.
    Tsong Y
    J Biopharm Stat; 1995 Mar; 5(1):95-114. PubMed ID: 7613562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing and reporting adverse drug reactions.
    Lucas LM; Colley CA
    West J Med; 1992 Feb; 156(2):172-5. PubMed ID: 1536067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse drug reactions.
    O'Donnell J
    Leg Med; 1994; ():229-67. PubMed ID: 7830481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of US poison centers in adverse drug reactions monitoring.
    Chyka PA
    Vet Hum Toxicol; 1999 Dec; 41(6):400-2. PubMed ID: 10592954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring of NSAIDs adverse effects based on spontaneous reports from Wrocław regional adverse drug reactions monitoring center.
    Jaźwińska-Tarnawska E; Wiela-Hojeńska A; Wolańczyk-Medrala A; Patkowski J; Nittner-Marszalska M; Głowacka K
    Acta Pol Pharm; 2012; 69(5):979-84. PubMed ID: 23061296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National adverse drug reaction reporting. 1984-1989.
    Faich GA
    Arch Intern Med; 1991 Aug; 151(8):1645-7. PubMed ID: 1872669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Food and Drug Administration monitoring of adverse drug reactions.
    Sills JM; Tanner LA; Milstien JB
    Am J Hosp Pharm; 1986 Nov; 43(11):2764-70. PubMed ID: 3799612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the assessment of adverse drug reactions from spontaneous reporting systems: the influence of under-reporting on odds ratios.
    van der Heijden PG; van Puijenbroek EP; van Buuren S; van der Hofstede JW
    Stat Med; 2002 Jul; 21(14):2027-44. PubMed ID: 12111885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The incidence of drug side effects with reference to organ systems. Experience of the spontaneous reporting system of the Swiss Drug Side Effect Center and Comprehensive Drug Monitoring].
    Kuhn M; Hartmann K; Maibach R; Capaul R; Gartmann JC
    Ther Umsch; 1993 Jan; 50(1):8-12. PubMed ID: 8378869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory decisions. Emphasis on safety issues.
    Strandberg K; Wiholm BE
    Med Toxicol; 1986; 1 Suppl 1():137-49. PubMed ID: 2950292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneously reported fatal suspected adverse drug reactions: a 10-year survey from Sweden.
    Wester K; Jönsson A; Spigset O; Hägg S
    Pharmacoepidemiol Drug Saf; 2007 Feb; 16(2):173-80. PubMed ID: 16739241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective.
    Mockenhaupt M; Kelly JP; Kaufman D; Stern RS;
    J Rheumatol; 2003 Oct; 30(10):2234-40. PubMed ID: 14528522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic adverse drug reactions: a preliminary report from the regional pharmacovigilance center, western Nepal.
    P S; P M; Pr S
    Pak J Pharm Sci; 2008 Oct; 21(4):465-7. PubMed ID: 18930872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneous reporting of adverse drug events by Korean regional pharmacovigilance centers.
    Shin YS; Lee YW; Choi YH; Park B; Jee YK; Choi SK; Kim EG; Park JW; Hong CS
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):910-5. PubMed ID: 19621345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety monitoring of new anti-malarials in immediate post-marketing phase.
    Edwards IR
    Med Trop (Mars); 1998; 58(3 Suppl):93-6. PubMed ID: 10212911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse drug reactions related to the use of non-steroidal anti-inflammatory drugs: results of spontaneous reporting from central India.
    Shrivastava MP; Chaudhari HV; Dakhale GN; Hiware SK; Solanke BP; Shinde A
    J Indian Med Assoc; 2013 Feb; 111(2):99-102, 106. PubMed ID: 24003566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse behavioral reactions attributed to triazolam in the Food and Drug Administration's Spontaneous Reporting System.
    Wysowski DK; Barash D
    Arch Intern Med; 1991 Oct; 151(10):2003-8. PubMed ID: 1929688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.